Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AH-008 Following Single Ascending Dose Administration in Healthy Subjects
This is a Phase 1, first-in-human (FIH), randomized, double-blind, placebo-controlled, parallel-group, single ascending dose (SAD) study to evaluate the safety…
Chemotherapy-induced Peripheral Neuropathy (CIPN)
Estimated
~$10 – $8,750
AnHorn Medicines Co. Ltd.NCT07697560
The Role Of Great Toe Strength And Its Association With The Severity Of Symptoms Of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Great Toe Strength (GTS) is a potential clinical biomarker that has been associated with functional mobility and health; Additionally, GTS has been identified …
Chemotherapy-induced Peripheral Neuropathy (CIPN)Healthy
Estimated
~$10 – $750
University of FloridaNCT07009717